arrow
M

Martin Schmidt-Hieber

medical university lausitz – carl thiem
H指数:35
被引数:3,878

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

30 years in service, 1996–2026: Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

30年服务历程,1996–2026:德国血液学和肿瘤学学会(DGHO)感染性疾病工作组(AGIHO)

2026-08-030
OA
Shortening of central venous catheter time in men with hematological and oncological diseases for prevention of central venous catheter-related bloodstream infections: a target-trial-emulation study

缩短血液和肿瘤疾病男性患者中心静脉导管留置时间以预防中心静脉导管相关血流感染:一项目标试验模拟研究

2026-07-100
OAAI
Central nervous system complications after allogeneic haematopoietic cell transplantation: best practice recommendations from the EBMT practice harmonisation and guidelines committee on epidemiology, outcome and neuroimaging

异基因造血细胞移植后的中枢神经系统并发症:EBMT实践协调和指南委员会关于流行病学、结局和神经影像学的最佳实践建议

2026-05-130
PRE
Symptom-guided approach to central nervous system complications in allogeneic hematopoietic cell transplant recipients: Best practice recommendations from the EBMT Practice Harmonisation and Guidelines committee

症状指导方法在异基因造血细胞移植受者中枢神经系统并发症中的应用:EBMT实践协调和指南委员会的最佳实践建议

2026-05-070
PRE
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case–control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT

造血干细胞移植后中枢神经系统障碍:一项来自EBMT传染病工作组与移植并发症工作组的病例对照观察性研究

2026-02-260
OAAI
CNS infections in patients with hematological or oncological diseases (including cellular therapies) – 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

血液病或肿瘤性疾病患者(包括细胞疗法)的CNS感染——德国血液学与肿瘤学学会(DGHO)感染性疾病工作组(AGIHO)指南的2024年更新版

2025-11-100
PRE
2024 update of the AGIHO guideline on diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients with solid tumours and hematological malignancies

2024年AGIHO指南关于实体瘤和血液恶性肿瘤成人中性粒细胞减少症患者发热待查(FUO)的诊断与经验性治疗的更新

2025-04-010
PRE
A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma
2024-01-010
PRE
Primary prophylaxis of invasive fungal diseases in patients with haematological malignancies: 2022 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO)

血液系统恶性肿瘤患者侵袭性真菌病的初级预防: 德国血液和医学肿瘤学会 (DGHO) 传染病工作组 (AGIHO) 建议的2022更新

2023-06-1346
OAAI
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4
2022-06-094
OAAI
Management of herpesvirus reactivations in patients with solid tumours and hematologic malignancies: update of the Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) on herpes simplex virus type 1, herpes simplex virus type 2, and varicella zoster virus

实体瘤和血液系统恶性肿瘤患者疱疹病毒再激活的管理: 德国血液和医学肿瘤学会 (DGHO) 感染性疾病工作组 (AGIHO) 关于1型单纯疱疹病毒、2型单纯疱疹病毒和水痘带状疱疹病毒的指南更新

2022-01-0734
OAAI
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

接受大剂量化疗和自体造血干细胞移植的患者感染的预防,诊断和治疗。德国血液学和医学肿瘤学会 (DGHO) 传染病工作组 (AGIHO) 建议的2020更新

2020-10-2042
OAAI
Salvage autologous transplant and lenalidomide maintenance vs. lenalidomide/dexamethasone for relapsed multiple myeloma: the randomized GMMG phase III trial ReLApsE
LEUKEMIA
IF13.4
2020-07-2137
PREAI